Current problems in the prevention and treatment of infections in patients with cirrhosis;Problemas actuales en la prevención y tratamiento de las infecciones en pacientes con cirrosis

Gastroenterologia y Hepatologia

Volumn 33, Issue 10, 2010, Pages 729-740

  Bellot, Pablo ^a,b   Jara Pérez López, Neftalí ^a   Martínez Moreno, Belén ^a   Such, José ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antibiotic prophylaxis; Bacterial infections; Cirrhosis; Sepsis; Spontaneous bacterial peritonitis

Indexed keywords

ALBUMIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; DECOMPENSATED LIVER CIRRHOSIS; EARLY DIAGNOSIS; ESOPHAGUS VARICES BLEEDING; HEMODYNAMICS; HUMAN; INFECTION; INFECTION PREVENTION; KIDNEY FAILURE; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; PROPHYLAXIS;

ACUTE KIDNEY INJURY; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; BLOOD COAGULATION DISORDERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EARLY DIAGNOSIS; ESOPHAGEAL AND GASTRIC VARICES; FLUOROQUINOLONES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION CONTROL; LIVER CIRRHOSIS; ORGAN SPECIFICITY; PERITONITIS; SEPSIS; SERUM ALBUMIN;

EID: 78649630302     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.02.004     Document Type: Article

References (49)

1. Fernandez J., Navasa M., Gomez J., Colmenero J., Vila J., Arroyo V., et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002, 35:140-148.
2. Foreman M.G., Mannino D.M., Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003, 124:1016-1020.
3. Christou L., Pappas G., Falagas M.E. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007, 102:1510-1517.
4. Wiest R., Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005, 41:422-433.
5. Albillos A., de la H.A., Gonzalez M., Moya J.L., Calleja J.L., Monserrat J., et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003, 37:208-217.
6. Such J., Frances R., Munoz C., Zapater P., Casellas J.A., Cifuentes A., et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002, 36:135-141.
7. Frances R., Zapater P., Gonzalez-Navajas J.M., Munoz C., Cano R., Moreu R., et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 2008, 47:978-985.
8. Bellot P., Garcia-Pagan J.C., Frances R., Abraldes J.G., Gonzalez-Navajas J.M., Navasa M., et al. Translocation of bacterial DNA is associated with worsening of the hyperkinetic systemic circulation and of intra-hepatic endothelial dysfunction in patients with cirrhosis and ascites. J Hepatol 2009, 50(Supl 1):S41.
9. Tsai M.H., Peng Y.S., Chen Y.C., Lien J.M., Tian Y.C., Fang J.T., et al. Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol 2009, 50:906-915.
10. Thabut D., Tazi K.A., Bonnefont-Rousselot D., Aller M., Farges O., Guimont M.C., et al. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 2007, 46:1893-1906.
11. Fernandez J., Escorsell A., Zabalza M., Felipe V., Navasa M., Mas A., et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 2006, 44:1288-1295.
12. Tsai M.H., Peng Y.S., Chen Y.C., Liu N.J., Ho Y.P., Fang J.T., et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006, 43:673-681.
13. Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
14. Sigal S.H., Stanca C.M., Fernandez J., Arroyo V., Navasa M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 2007, 56:597-599.
15. Terg R., Gadano A., Cartier M., Casciato P., Lucero R., Munoz A., et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009, 29:415-419.
16. Poca M., Concepción M., Casas M., Álvarez C., Gordillo J., Guarner-Argente C., et al. Renal failure and mortality in cirrhotic patients with spontaneous bacterial peritonitis and low riak of mortality in non-treated with albumin. J Hepatol 2009, 50(Suppl 1):S43.
17. Rimola A., Bory F., Teres J., Perez-Ayuso R.M., Arroyo V., Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985, 5:463-467.
18. Hou M.C., Lin H.C., Liu T.T., Kuo B.I., Lee F.Y., Chang F.Y., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004, 39:746-753.
19. Pannen B.H., Bauer M., Zhang J.X., Robotham J.L., Clemens M.G. Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 1996, 270(1 Pt 2):H7-H15.
20. Thalheimer U., Triantos C.K., Samonakis D.N., Patch D., Burroughs A.K. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005, 54:556-563.
21. Shawcross D.L., Davies N.A., Williams R., Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004, 40:247-254.
22. Nousbaum J.B., Cadranel J.F., Nahon P., Khac E.N., Moreau R., Thevenot T., et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 2007, 45:1275-1281.
23. Parsi M.A., Saadeh S.N., Zein N.N., Davis G.L., López R., Boone J., et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology 2008, 135:803-807.
24. Rimola A., Garcia-Tsao G., Navasa M., Piddock L.J., Planas R., Bernard B., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000, 32:142-153.
25. Bert F., Andreu M., Durand F., Degos F., Galdbart J.O., Moreau R., et al. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications. Eur J Clin Microbiol Infect Dis 2003, 22:10-15.
26. Song J.Y., Jung S.J., Park C.W., Sohn J.W., Kim W.J., Kim M.J., et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci 2006, 21:666-671.
27. Angeloni S., Leboffe C., Parente A., Venditti M., Giordano A., Merli M., et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol 2008, 14:2757-2762.
28. Umgelter A., Reindl W., Miedaner M., Schmid R.M., Huber W. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection 2009, 37:2-8.
29. Song K.H., Jeon J.H., Park W.B., Park S.W., Kim H.B., Oh M.D., et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 2009, 9:41.
30. Yakar T., Guclu M., Serin E., Aliskan H. A Recent Evaluation of Empirical Cephalosporin Treatment and Antibiotic Resistance of Changing Bacterial Profiles in Spontaneous Bacterial Peritonitis. Dig Dis Sci 2009.
31. Cheong H.S., Kang C.I., Lee J.A., Moon S.Y., Joung M.K., Chung D.R., et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009, 48:1230-1236.
32. Singh N., Wagener M.M., Gayowski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect 2003, 9:531-537.
33. Acevedo J., Fernandez J., Castro M., García O., Rodriguez de Lope C., Navasa M., et al. Current efficacy recommended empirical antibiotic therapy in patients with cirrhosis and bacterial infection. J Hepatol 2009, 50(Suppl 1):S5.
34. Soriano G., Castellote J., Alvarez C., Girbau A., Gordillo J., Baliellas C., et al. Secondary bacterial peritonitis in cirrhosis: A retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol 2009.
35. Koch D.G., Arguedas M.R., Fallon M.B. Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy. Dig Dis Sci 2007, 52:2225-2228.
36. Liu B.M., Chung K.J., Chen C.H., Kung C.T., Ko S.F., Liu P.P., et al. Risk factors for the outcome of cirrhotic patients with soft tissue infections. J Clin Gastroenterol 2008, 42:312-316.
37. Llach J., Rimola A., Navasa M., Gines P., Salmeron J.M., Gines A., et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992, 16:724-727.
38. Novella M., Sola R., Soriano G., Andreu M., Gana J., Ortiz J., et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997, 25:532-536.
39. Grange J.D., Roulot D., Pelletier G., Pariente E.A., Denis J., Ink O., et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 1998, 29:430-436.
40. Fernandez J., Navasa M., Planas R., Montoliu S., Monfort D., Soriano G., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007, 133:818-824.
41. Terg R., Fassio E., Guevara M., Cartier M., Longo C., Lucero R., et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol 2008, 48:774-779.
42. Aparicio J.R., Such J., Pascual S., Arroyo A., Plazas J., Girona E., et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999, 31:277-283.
43. Gascon I., Pascual S., Plazas J., Sanchez J., Frances R., Mas P., et al. Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis. Aliment Pharmacol Ther 2005, 21:701-707.
44. Perez-Paramo M., Munoz J., Albillos A., Freile I., Portero F., Santos M., et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000, 31:43-48.
45. Abraldes J.G., Tarantino I., Turnes J., Garcia-Pagan J.C., Rodes J., Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003, 37:902-908.
46. Bauer T.M., Fernandez J., Navasa M., Vila J., Rodes J. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 2002, 36:501-506.
47. Batuwitage B.T., Kingham J.G., Morgan N.E., Bartlett R.L. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007, 83:66-68.
48. Herzig S.J., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
49. Bajaj J.S., Zadvornova Y., Heuman D.M., Hafeezullah M., Hoffmann R.G., Sanyal A.J., et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009, 104:1130-1134.